Asset Dedication LLC’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-235
Closed -$23.5K 1178
2025
Q3
$23.5K Buy
+235
New +$21.2K ﹤0.01% 647
2019
Q2
Sell
-450
Closed -$41K 647
2019
Q1
$41K Buy
+450
New +$38.3K 0.01% 294

Other funds holding XBI

Asset Dedication LLC's XBI Position: Q4 2025 in Review

Asset Dedication LLC sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2025, closing a stake of 235 shares — an estimated $23.5K sold.

Asset Dedication LLC first reported a position in XBI in Q1 2019 and held it in 2 quarters. The position peaked at $41K in Q1 2019. 813 funds tracked by Wall St. Rank hold XBI as of Q4 2025.

  • Asset Dedication LLC reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2025 after selling out during the quarter.
  • Asset Dedication LLC sold 235 State Street SPDR S&P Biotech ETF shares in Q4 2025, an estimated $23.5K.
  • Asset Dedication LLC first reported a position in State Street SPDR S&P Biotech ETF in Q1 2019 and held it in 2 quarters.
  • Asset Dedication LLC's State Street SPDR S&P Biotech ETF position peaked at $41K in Q1 2019.
  • 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2025.

Based on Asset Dedication LLC's 13F filing for Q4 2025, filed 26 Jan 2026.